JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
TCRX - Tscan Therapeutics, Inc.
USD | NASDAQ | Healthcare
Summary
Summary TCRX Stock
Financials
Financials TCRX Stock
Loading...
Loading...
Income Statement
Income Statement TCRX Stock
Balance Sheet
Balance Sheet TCRX Stock
Cash Flow Statement
Cash Flow Statement TCRX Stock
Loading...
Loading...
TCRX Financials - Tscan Therapeutics Income & Cash Flow | Ledgeburg
Home
Stocks
Tscan Therapeutics, Inc. (TCRX)
Financials
Financials of TCRX
Loading...
Loading...
Loading...
Loading...
Revenue
$10.325M
Operating Income
$-135.813M
Net Income
$-129.766M
Share Count (Basic)
129.777415M
Operating Cash Flow
$-135.319M
Free Cash Flow
$-139.726M
Cash And Short-Term Equivalents
$152.406M
Total Debt
$32.534M
Annual
Quarterly
Revenue $USD
0
5M
10M
15M
20M
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue $USD
0
1M
2M
3M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
-120M
-100M
-80M
-60M
-40M
Annual
Quarterly
Margins
Gross
Operating
Net
-5000%
-4000%
-3000%
-2000%
-1000%
0%
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-35M
-30M
-25M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-3000%
-2500%
-2000%
-1500%
-1000%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26